Patent ductus venosus does not lead to alimentary galactosaemia in preterminfants

Citation
D. Fugelseth et al., Patent ductus venosus does not lead to alimentary galactosaemia in preterminfants, ACT PAEDIAT, 90(2), 2001, pp. 192-195
Citations number
22
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
ACTA PAEDIATRICA
ISSN journal
08035253 → ACNP
Volume
90
Issue
2
Year of publication
2001
Pages
192 - 195
Database
ISI
SICI code
0803-5253(200102)90:2<192:PDVDNL>2.0.ZU;2-3
Abstract
The aim of this study was to investigate if an open ductus venosus represen ting a portal-caval shunt can lead to transient "alimentary galactosaemia" in preterm infants fed human breast milk. Twenty-six preterm infants (28-34 wk of gestational age) with open ductus venosus were included. Capillary b lood samples for measurement of galactose and glucose were collected before , 30 and 50 min after a meal with breast milk (range 12-23 mL/kg). Ultrasou nd studies of the blood flow in the ductus venosus, truncus coeliacus, supe rior mesenteric artery and left hepatic vein were performed before and 30 m in after the meal. There was a significant rise in blood glucose after 30 a nd 50 min, indicating a sufficient lactose load. Galactose, however, was ei ther not detectable or was just above the detectable limit (0.1-0.4 mmol/L) , with no changes after the meal. An increased flow velocity was found in t he ductus venosus and superior mesenteric artery after 30 min (p less than or equal to 0.001) indicating increased entero-hepatic and portal-caval shu nting. Conclusion: A patent ductus venosus does not lead to a significant hypergal actosaemia in preterm infants fed human breast milk. Thus, in respect to br east-milk feeding, this is regarded safe in healthy preterm infants even wi th an open ductus venosus. The increased portal-caval shunting may, however , influence the hepatic metabolism of other enterally absorbed substances.